EUVIMEDObjevte EUVIMED
Crossref

Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer

Xunxi Lu iD, Zongchao Gou iD, Hong Chen iD, Li Li, Fei Chen, Chunjuan Bao, Hong Bu, Zhang Zhang

The Journal of Pathology · 2025-03 · 265 (3) · 385-399

DOI: 10.1002/path.6395 ↗

At a glance

Journal article in The Journal of Pathology, published online on 2025-01-23. Written by Xunxi Lu and 7 co-authors. Institution: Department of Pathology, West China Hospital, Sichuan University, Chengdu, PR China. Major MEDLINE topics: Triple Negative Breast Neoplasms, Cancer-Associated Fibroblasts, Extracellular Matrix. Cited 53 times so far (Crossref); 55 references. Funded by: National Natural Science Foundation of China, Sichuan Science and Technology Program, Post-Doctor Research Project, West China Hospital, Sichuan University.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The impact of high heterogeneity of cancer‐associated fibroblasts (CAFs) on triple‐negative breast cancer (TNBC) immunotherapy response has not been fully elucidated, restricting progress in precision immuno‐oncology. We integrated single‐cell transcriptomic data from 18 TNBC patients and analyzed fibroblast subpopulations. Extracellular matrix CAFs (ecmCAFs) were identified as a fibroblast subpopulation with distinct ECM‐associated characteristics. The ecmCAFs were significantly enriched in TNBC patients with residual disease after neoadjuvant immunotherapy and contributed to a fibrotic tumor microenvironment and T‐cell exclusion. Secreted phosphoprotein 1 ( SPP1 ) positive macrophages (SPP1 + Mφs) were closely localized to ecmCAFs and produced more transforming growth factor beta ( TGFB1 ), interleukin 1 beta ( IL1B ), and SPP1 under hypoxic conditions. SPP1 + Mφs were found to facilitate the differentiation of normal breast fibroblasts to ecmCAFs, thus promoting ECM remodeling and stromal fibrosis. Our work revealed the critical role of ecmCAFs in generating a desmoplastic architecture and driving immunosuppression in TNBC. © 2025 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Triple Negative Breast NeoplasmsCancer-Associated FibroblastsExtracellular MatrixHumansFemaleTumor MicroenvironmentFibrosisOsteopontinMacrophagesSingle-Cell Analysis

Author keywords

cancer‐associated fibroblastsextracellular matriximmunotherapymacrophagestriple‐negative breast cancertumor microenvironment

Substances

OsteopontinSPP1 protein, human

Authors and institutions

  • Department of Pathology, West China Hospital, Sichuan University, Chengdu, PR China.
  • Laboratory of Breast Pathology and Artificial Intelligence, West China Hospital, Sichuan University, Chengdu, PR China.
  • Breast Center, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, PR China.
  • Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, PR China.

ORCID profiles: Xunxi Lu, Zongchao Gou, Hong Chen

Funding

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program
  • Post-Doctor Research Project, West China Hospital, Sichuan University

Cite

APA

Lu, X., Gou, Z., Chen, H., Li, L., Chen, F., Bao, C., Bu, H., & Zhang, Z. (2025). Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer. The Journal of Pathology, 265(3), 385-399. https://doi.org/10.1002/path.6395

Vancouver

Lu X, Gou Z, Chen H, Li L, Chen F, Bao C, et al. Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer. The Journal of Pathology. 2025;265(3):385-399. doi:10.1002/path.6395

BibTeX
@article{Lu2025,
  author = {Lu, Xunxi and Gou, Zongchao and Chen, Hong and Li, Li and Chen, Fei and Bao, Chunjuan and Bu, Hong and Zhang, Zhang},
  title = {Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer},
  journal = {The Journal of Pathology},
  year = {2025},
  volume = {265},
  number = {3},
  pages = {385--399},
  doi = {10.1002/path.6395}
}
Start for free →